The Federal Trade Commission won a Third Circuit ruling upholding a pause on hospital operator Hackensack Meridian Health’s acquisition of Englewood Healthcare Foundation while the agency proceeds with an administrative trial to permanently block the deal.
The antitrust regulatory agency established that “there is a reasonable probability that the merger will substantially impair competition,” according to an opinion Tuesday by a three-judge panel of the U.S. Court of Appeals for the Third Circuit.
The two New Jersey-based healthcare systems signed their merger deal, which took effect in September 2019. Hackensack committed $439.5 million in capital investments over eight years and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.